Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Srus Imaging Of The Lymph Nodes Before Surgery Or Biopsy

Research Leaders

6 sponsors active, led by Fudan University

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 1/2 (1)

Trial Status

Recruiting2
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07155954Recruiting

Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes

NCT06684418Recruiting

Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer

NCT03362359Phase 1/2Completed

Ga-68-PSMA-11 in High-risk Prostate Cancer

Showing all 3 trials

Research Network

Common Treatments

  • Srus Imaging Of The Lymph Nodes Before Surgery Or Biopsy1
  • Chest Enhanced Ct1
  • Ga68psma111

Active Sponsors

  • Fudan University1
  • Friedrich-Alexander-Universität Erlangen-Nürnberg1
  • ABX CRO1
  • German Cancer Research Center1
  • University Hospital Freiburg1

Top Investigators

Related Conditions

  • Prostate Cancer1
  • Lymphatic Tuberculosis1
  • Nsclc Nonsmall Cell Lung Cancer1
  • Prostate Cancer Metastatic1
  • Artificial Intelligence Ai1

Activity Timeline